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Epidemiology of Gastroesophageal Reflux 
Disease in Asia: A Systematic Review
Hye-Kyung Jung
Department of Internal Medicine, School of Medicine, Ewha Womans University, Seoul, Korea
ㅋ
Ethnic and geographical differences are important factors in studying disease frequencies, because they may highlight the envi-
ronmental or genetic influences in the etiology. We retrieved the studies which have been published regarding the epidemio-
logic features of gastroesophageal reflux disease (GERD) in Asia, based on the definitions of GERD, study settings, publication 
years and geographical regions. From the population-based studies, the prevalence of symptom-based GERD in Eastern Asia was 
found to be 2.5%-4.8% before 2005 and 5.2%-8.5% from 2005 to 2010. In Southeast and Western Asia, it was 6.3%-18.3% 
after 2005, which was much higher than those in Eastern Asia. There were robust epidemiologic data of endoscopic reflux 
esophagitis in medical check-up participants. The prevalence of endoscopic reflux esophagitis in Eastern Asia increased from 
3.4%-5.0% before 2000, to 4.3%-15.7% after 2005. Although there were only limited studies, the prevalence of extra-eso-
phageal syndromes in Asia was higher in GERD group than in controls. The prevalence of Barrett’s esophagus was 0.06%- 
0.84% in the health check-up participants, whereas it was 0.31%-2.00% in the referral hospital settings. In summary, the prev-
alence of symptom-based GERD and endoscopic reflux esophagitis has increased in Asian countries. However, the prevalence 
of Barrett’s esophagus in Asia has not changed and also still rare. 
(J Neurogastroenterol Motil 2011;17:14-27)
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Introduction
Gastroesophageal reflux disease (GERD) broadly includes 
the whole spectrum of reflux disease, from intermittent symptoms 
like heartburn or acid regurgitation to endoscopic reflux esoph-
agitis and Barrett’s esophagus.
1 It usually gives a considerable 
impact on the quality of the patient’s life not only by the symp-
toms, but also by the following consultation procedures and med-
ical cares. While GERD is a common disease and also the major 
upper gastrointestinal problem in Western countries, its preva-
lence amongst Asian has been reported to be relatively low.
2-4 
During the recent decade, several studies about prevalence of 
symptom-based GERD and endoscopic reflux esophagitis have 
revealed generally higher number of patients compared to other 
previous Asian studies. Time trend studies have also shown the 
increase of prevalence both in symptom based-GERD and endo-
scopic reflux esophagitis.
5 
Heartburn and acid regurgitation are the characteristic symp-
toms of GERD. Heartburn is defined as a burning sensation at Epidemiology of GERD in Asia
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the retrosternal area. However, different criteria of GERD have 
been published from all over the world including Asia, with the 
frequency of its symptoms differing from once a week to even 
once a year. Furthermore, it also has been attributed to the lack of 
the exact word for heartburn in some Asian languages, such as 
Chinese or Korean.
6 In addition, there has not been any con-
sensus distinguishing GERD from dyspepsia. 
In Asia, endoscopic reflux esophagitis is quite commonly di-
agnosed because the cost of endoscopic examination is relatively 
inexpensive. Actually, a lot of asymptomatic people get the upper 
endoscopic examinations for gastric cancer screening and com-
prehensive medical check-up. The major limitation of studies 
with individuals in screening program is that it might not repre-
sent the general population. However, such studies have advan-
tages of their large sample size and consistent diagnostic man-
ners. 
This paper was aimed to review the epidemiologic aspect of 
GERD and its related disease manifestations, such as endoscopic 
reflux esophagitis, Barrett’s esophagus and extra-esophageal syn-
drome, according to various definitions, study settings, publica-
tion years and geographical regions in Asia. 
Methods
Identification and Eligibility Assessment of 
Relevant Studies 
A systematic PubMed search was performed to identify all of 
the reports written about the prevalence of GERD, published 
from January 1995 to October 2010, using combinations of the 
following index terms: “gastroesophageal reflux disease,” “reflux,” 
“gastroesophageal reflux” or “esophagitis” and “prevalence” or 
“epidemiology.” Only the papers published in English were re-
viewed. Included studies had to meet all of these 3 following cri-
teria: (1) including epidemiologic studies performed with at least 
200 subjects gathered by population-based or medical check-up 
settings; (2) having detailed description of GERD definition or 
its related manifestations and (3) subjecting any sample type, in-
cluding subjects from tertiary hospitals, to collect data about ex-
tra-esophageal symptoms or Barrett’s esophagus.
Data Extraction
Following information was abstracted from each study in-
cluded: the year of publication, study periods, country of sub-
jects, sample types (the population-based type, subjects who un-
derwent the medical check-up or those from referral hospitals), 
study design (derived from case-control, cohort or other cross- 
sectional studies), sample size and prevalence of GERD, reflux 
esophagitis, Barrett’s esophagus or extra-esophageal syndromes 
of GERD. 
All studies were sub-grouped by each geographical region, 
based on Globocan 2008, the project of the International Agency 
for Research on Cancer which provides contemporary estimates 
of the incidence, prevalence and mortality from major types of 
cancers for all countries over the world.
7 The Asian geographic 
area includes these 4 regions of Eastern (China, Japan, Korea and 
Taiwan), Southeastern (Malaysia, Singapore and Thailand), Sou-
th Central (India, Iran and Pakistan) and Western (Israel and 
Turkey) Asia. 
Among a total of 3,440 papers searched by those key words, 
1,696 papers were excluded from this study because they were not 
written by English or their subjects were not adults or human. 
Only 70 studies were included in the final analysis. 
Prevalence of Symptom-Based 
  Gastroesophageal Reflux Disease
Details of published studies satisfying the inclusion criteria 
on the symptom-based GERD (ie, symptoms of heartburn or 
acid regurgitation occurring at least once a week), in the pop-
ulation-based studies are listed in Table 1. They generally used 
methods of face-to-face or telephone interviews or the postal que-
stionnaires. 
The largest sample group was consisted of Eastern Asia stud-
ies, followed by those from South Central Asia (Figure). The pre-
valence of symptom-based GERD in Eastern Asia was 5.2%- 
8.5%
8-13 from 2005 to 2010, while it was 2.5%-4.8%
14-16 before 
2005. Most studies in South Central Asia were conducted in 
Iran. The prevalence of GERD in Iran was 6.3%-18.3%
17-20 
from 2005 to 2010, which seemed more prevalent than in East-
ern Asia. Before 2005, 2 population-based studies from this coun-
try with different definitions of GERD also showed similar re-
sults.
21,22 On the other hand, the time trend of GERD prevalence 
showed drastic change between 2 cross-sectional surveys of the 
general population in Singapore in Southeastern Asia. The first 
survey which was held in 1994 showed the prevalence of GERD 
by at least monthly symptoms to be around 5.5% ± 1.5%, while 
it has increased to 10.5% ± 2.0% after 5 years (OR, 2.2; 95% 
CI, 1.0-5.2; P = 0.05).
23 However, the sample size of this study 
was relatively small and this increased result might also have been Hye-Kyung Jung
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Table 1. Population-Based Study of Gastroesophageal Reflux Disease in Asia
Study Country
 Sample
 size
Publi-
cation
year
Study
year
Definition of study/Methods Prevalence
Eastern Asia
    He et al
8 China 16,091 2010   2007-
2008
Self-reported questionnaires At least weekly, 5.2%; at least twice a week, 3.1% (2.4% 
in urban and 3.8% in rural area)
    Wang et al
9
    Ma et al
67
China      919 2009   2005-
2006
GERD, heartburn or regurgitation  
over 1 wk recall period by RDQ
GERD, 6.2% (95% CI, 4.64-7.76); experienced eat-
ing and drinking problems, 47%; sleep impairment, 
32%; reduced work productivity, 32%; GERD re-
lated with impaired HRQOL
    Lee et al
10 Korea   1,443 2009 2005 Direct interview GERD, 8.5%; overlap with dyspepsia in 27% and with 
IBS in 24%
    Yang et al
11 Korea   1,044 2008 2004 Telephone survey with random num-
ber; GERD, heartburn or acid re-
gurgitation at least weekly
7.1%; risk factors: educational level for heartburn, ag-
ing for acid regurgitation
    Li et al
12 China 15,283 2008   2004-
2005
Self-reported questionnaires; GERD, 
RDQ score > 12
7.28% (95% CI, 6.87-7.69), men (7.8%) vs women 
(6.7%) (P < 0.05); risk factors: old age, night-shift 
work, heavy work burdens, single or divorced people, 
increase intake of greasy or sweet foods, excessive 
eating and constipation
    Chen et al
13 China   3,338 2005 - Direct interview; GERD, heartburn 
or acid regurgitation at least weekly
GERD, 6.2%; no gender difference; risk factors: mari-
tal status, heavy burden of work for GERD
    Wang
      et al
42
China   2,532 2004 2003 Symptomatic GER, composite score 
of following 3 GER symptoms ≥ 3
Weekly heartburn, 4.1% (103), acid regurgitation, 
7.8% (197), food regurgitation, 3.3% (83), SGER, 
17.0%
    Wong
      et al
14
China  
  (Hong 
  Kong)
  2,209 2003 2002 Telephone survey; GERD, heartbu-
rn and/or acid regurgitation at least 
weekly
GERD, 2.5%; risk factors for health care seeking: 
female gender, depression, social morbidity
    Jeong et al
15
    Cho et al
41
Korea   1,417 2008   2000-
2001
Direct interview; GERD, heartburn 
and/or acid regurgitation at least 
weekly
3.5% (95% CI, 2.6-4.5); GERD exhibited significant-
ly worse HRQOL
    Cheung
      et al
16
China  
  (Hong 
  Kong)
  1,649 2007 1996 Telephone survey: GERD, heartbu-
rn andor acid regurgitation at least 
weekly
GERD, 4.8% (79); IBS, 4% (68); risk factor: overlap 
of IBS (OR, 3.0;  95% CI, 1.05-6.27)
South Eastern Asia
    Lim et al
23 Singapore 237 in
  1999
696 in
  1994
2005 1994 
vs 
1999
Direct interview: GERD, retroster-
nal burning or acid regurgitation at 
least monthly
GERD, 10.5% ± 2.0% in 1999 vs 5.5% ± 1.5% in 
1994
    Ho et al
68 Singapore      696 1998 - GERD, heartburn or acid regurgita-
tion more than monthly
Ethnic-adjusted rate of 1.6% (95% CI, 0.6-2.6): In-
dians, 7.5% (95% CI, 4.4-11.7), Chinese, 0.8% (95% 
CI, 0.1-3.0), Malays, 3.0% (95% CI, 1.2- 6.1); men
> women (5.6% vs 1.5%, P <0 . 0 1 )
attributed to the increased awareness.
The prevalence in Western Asia was found to be the highest 
among the whole Asian region as represented by 20% in Turkey. 
One population-based study performed in Israel (2007) also re-
ported the high prevalence of GERD symptoms, including 6.5% 
of retrosternal burning, 5.2% of retrosternal pain, 10.4% of acid 
taste in the mouth and 7.9% of the reflux of gastric contents.
24
Prevalence of Endoscopic Reflux 
  Esophagitis
The list of studies published regarding the prevalence of en-Epidemiology of GERD in Asia
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Table 1. Continued
Study   Country
 Sample
 size
Publi-
cation
year
Study
year
Definition of study/Methods Prevalence
South Central Asia
    Mostaghni
      et al
69
Iran      717 2009 2006 GERD, at least weekly any symp-
toms of heartburn, regurgitation, 
chest pain, dysphagia, hoarseness 
and cough
33% (237)
    Solhpour
      et al
17
Iran   5,733 2008 - Direct interview: symptoms of reflux 
at least once a week
GERD, 9.1%; no association with obesity and GERD
    Nasseri-
      Moghaddam
      et al
18
Iran 2,057
2008
-
Direct interview: GERD, heartburn 
or acid regurgitation at least weekly
GERD, 18.2%; risk factors: female gender (OR, 1.55; 
95% CI, 1.01-2.41), BMI > 30 kg/m
2 (OR, 1.79; 
95% CI, 1.03-3.12), less education, smoking, NSAID
use and GERD in spouse
    Somi et al
19 Iran    620 2006 2005 GERD, heartburn or acid regurgita-
tion at least weekly
GERD, 6.3%; no gender difference
    Nouraie
      et al
20
Iran 1,202 2007   2004-
2005
Telephone survey with random num-
ber: GERD, heartburn or acid re-
gurgitation at least weekly 
6.8% (95% CI, 5.4- 8.3); no relationship with gender, 
age or education.
    Saberi-Firoozi
      et al
21
Iran 1,978 2007 2004 GERD, heartburn or acid regurgita-
tion at least 3 times a week
GERD, 15.4% (304); risk factor: consulting with phy-
sicians, 24.8%
    Ehsani et al
22 Iran    700 2007 1999 GERD, heartburn or acid regurgita-
tion
GERD, 39.7% (278)
Western Asia 
    Sperber
      et al
24
Israel    981 2007 - Telephone survey: suffered GERD 
symptoms at least  weekly.
Reported retrosternal burning, 6.5%; retrosternal pain, 
5.2%; acid taste in the mouth, 10.4%; reflux of gastric 
content, 7.9%
    Kitapçioğlu
      et al
70
Turkey    630 2007   1998-
1999
Direct interview: GERD, heartburn 
or acid regurgitation at least weekly
GERD, 20%
    Bor et al
48 Turkey 630 
in low-
income
region
2005 - GERD, heartburn and/or acid eruc-
tation occurring at least weekly
GERD, 20% 
GERD, gastroesophageal reflux disease; RDQ, Reflux Disease Questionnaire, HRQOL; health-related quality of life; IBS, irritable bowel syndrome; SGER, 
symptomatic gastroesophageal reflux; BMI, body mass index.
doscopic reflux esophagitis is summarized in Tables 2 and 3. Most 
endoscopy-based studies were conducted with medical check-up 
participants or patients having upper gastrointestinal symptoms 
who visited the referral hospitals. Most of the GERD endoscopic 
studies were consisted of Eastern Asian studies including Japan, 
China and Korea. The prevalence of endoscopic reflux esoph-
agitis in Eastern Asia was 3.4%-5.0%
25,26 before 2000, with these 
2 studies using the definition of reflux esophagitis by Savary- 
Miller classification, while other 9 studies showed results of 
6.6%-15.0%
27-31 from 2000 to 2005 and 4.3%-15.7%
32-35 after 
2005, with the definition by LA classification. However, it is 
quite uncertain why such a wide range of prevalence has been 
found for endoscopic reflux esophagitis. There might be some 
variability in interpreting the endoscopic findings. Furthermore, 
several studies were conducted in retrospective manner and might 
have under- or over-estimated the exact prevalence of endoscopic 
reflux esophagitis. 
The intensity and frequency of reflux induced symptoms are 
poor predictors for finding the presence or the severity of endo-
scopic mucosal breaks (erosion or ulcer). In the medical check-up 
studies, the prevalence of GERD based on symptoms like heart-
burn or acid regurgitations at least once a week was 5.0%- 
8.2%,
31,34,36 which were similar with those of population-based 
studies. Hye-Kyung Jung
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Table 2. Epidemiology of Gastroesophageal Reflux Disease in Asian Medical Check-up People
Study   Country
 Sample
 size
Publi-
cation
year
Study
year
Definition of study/Methods Prevalence
Eastern Asia
    Noh et al
35 Korea   2,388 2010   2008-
2009
RE by LA classification; GERD, 
heartburn at least weekly; Rome III 
criteria for FGIDs
RE, 12.0%; NERD, 3.1%; more frequently overlap 
with FGIDs in NERD than RE
    Kaji et al
36 Japan   2,680 2010   2008-
2009
Self-reported questionnaires/at least 
weekly symptoms; Rome III crite-
ria for FGIDs
GERD, 7.7%; FD, 10.0%, IBS, 14.2%; overlap with 
FGIDs, 46.9%
    Matsuzaki
      et al
71
Japan   2,563  2010 - NERD, GER symptoms with GER 
at VE; FH, GER symptoms with-
out GER at VE
GER by VE, 11.2% (283); NERD, 12.4% (35/283); 
FH, 26.5% (75/283)
    Yamagishi
      et al
33
Japan   6,504 2009 - RE by LA classification; symptoms 
(yes/no)
RE, 6.3%; positive correlation between prevalence of 
heartburn/dysphagia and severity of RE
    Kim et al
34 Korea 25,536 2008 2006 RE by LA classification; GERD, 
heartburn or acid regurgitation at 
least weekly; NERD, GERD symp-
toms without RE
RE, 8% (2,019): LA-A, 6.0% (1,497), LA-B, 2.0% 
(471), LA-C, 0.2% (47), LA-D, 0.02% (4); GERD, 
5% (1,161); NERD, 4% (996); risk factors for
GERD: male, a H. pylori eradication history, alcohol 
and obesity; risk factors for NERD: female, age, low 
BMI, low monthly income, high fasting sugar, smok-
ing and a stooping posture at work and antibiotic 
usage
    Peng et al
32 China   2,580 2009   2006-
2007
RE by LA classification; GERD, 
heartburn and/or acid regurgitation 
during the previous 6 mo
RE, 4.3% (110); asymptomatic RE, 33.6% of RE; risk 
factors: male, alcohol use, hiatus hernia and reflux 
symptoms.
    Tseng
       et al
29
China 19,812 2008   2003-
2006
RE by LA classification; symptom 
questionnaires
RE, 15.7% (3,129): LA-A, 78.2% (2,446), LA-B, 
16.0% (502), LA-C, 5.2% (164), LA-D 0.05% (17)
    Kang et al
31 Korea   2,457 2007   2004-
2005
RE by LA classification; GERD, 
heartburn or acid regurgitation at 
least weekly
GERD 8.2%; RE, 6.6%; RE according to BMI
(5.6%, 8.1% and 15.5% for BMI < 25, 25-30 and >
30, respectively; P = 0.002)
    Yamagishi
      et al
72
Japan 82,894 2008 2003 Symptom questionnaire; sometimes 
experienced of heartburn
GERD symptom, 15.8% in men and 20.7% in women
 
    Lee et al
30 Korea   3,188 2008   2003-
2005
Erosive esophagitis; RE by LA cla-
ssification; GERD, heartburn or 
acid regurgitation at least weekly
Erosive esophagitis, 9.2%: LA-A, 74.7% (218), LA- 
B, 20.1% (61), LA-C, 4.5% (13), LA-D, 0.7% (2); 
obesity over BMI ≥ 30 kg/m
2 (OR = 3.3, 95% CI, 
1.8-6.1)
    Fujiwara
      et al
73
Japan     2,662 2005 - Symptom questionnaires; GERD, 
heartburn and/or acid eructation
GERD: daily symptoms, 2.1% (124); at least twice a 
week, 4.6% (275); at least twice a month, 12.8% (773)
    Fujiwara
      et al
28
Japan      569 2003   2000-
2001
RE by LA classification RE, 7.7% (42); atrophic gastritis, inversely associated 
with RE (OR, 0.15; 95% CI, 0.07-0.36)
    Fujimoto
      et al
27
Japan   6,010 2003 - Symptom questionnaires; RE by LA 
classification
RE, 15%: grade A (9.6%), grade B (4.6%) and grade 
C + D (2.0%); heartburn, 27.0%; dysphagia, 16.9%; 
odynophagia, 19.2%; acid regurgitation, 7.1%
    Lien et al
26 Taiwan 1,902 
in 2002  
2,044 
in 1995
2009 2002, 
1995
RE by endoscopy RE, 5% in 1995 and 12.6% in 2002 (P < 0.0001); 
aging related with RE with dose-response manner
    Lee et al
25 Korea   7,015 2001   1996-
1997
Endoscopy: RE by SM classification RE, 3.4% (242): grade 1 (98.3%) and grade 2 (1.7%); 
hiatal hernia, 9.2%; men : women = 7 : 1
RE, reflux esophagitis; LA, Los Angeles; GERD, gastroesophageal reflux disease; FGID, functional gastrointestinal disorder; NERD, non-erosive reflux disease; VE,
videoesophagography; FH, functional heartburn; SM, Savary-Miller; FD, functional dyspepsia; IBS, irritable bowel syndrome; H. pylori, Helicobacter pylori.Epidemiology of GERD in Asia
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Table 3. Epidemiology of Gastroesophageal Reflux Disease in Asian Referral Hospital
Study Country
  Sample 
size
Publi-
cation
year
Study
year
 Definition of study/Methods Prevalence
Eastern Asia
    Kusano
      et al
46
Japan 2,426 in 100 consecutive 
patients at nation-wide 
35 institutions
2009 2005 GERD, heartburn twice week-
ly or more; RE by LA cla-
ssification
GERD, 13.7%; NERD, 9.8% (71.7% among 
GERD)
    Sakaguchi
      et al
74
Japan 2,225 in referral hospital 2008   2005-
2006
GER symptoms, heartburn or 
water brash symptoms twice 
or more per week; RE by LA 
classification; GERD includ-
ing RE and NERD
GERD, 25.9%; RE, 11.1%; NERD, 14.7%; 
GERD according to BMI: 21.0% in thin 
patients, 24.4% in normal BMI and 31.9% in 
obesity
    Du
      et al
75
China 10 referral hospitals: 2,231 2008   2004-
2005
GERD, heartburn, substernal 
chest pain, acid eructation and 
food regurgitation; RE by 
endoscopy
GERD, 31.7% (1,701); RE, 20.8% (464); 
NERD, 10.6% (237); asymptomatic RE, 
37.3% (173); risk factors for RE: old age, 
male, moderate working burden, divorced/ 
widowed and strong tea drinking 
    Chen
      et al
39
Taiwan Referral settings: 7,479 in 
2000 and 10,195 
in 2007
2010   2000-
2007
GERD, at least weekly heart-
burn and/or acid regurgita-
tion with RE; NERD, sy-
mptoms without RE
In patients with GI symptoms, RE, 20.7% at 
2000 and 51% at 2007; In screening en-
doscopy, RE, 14.5% at 2000 and 23.5% at 
2007; GERD, 3.4% at 2000 and 12.4% at 
2007; NERD 1.8% at 2000 and 2.3% at 
2007
    Miyamoto
      et al
76 Japan
241 non-GERD patients 
cohort
2008 1998, 
2004
GERD, QUEST question-
naire > 6
Incidence of GERD, 15.4% (37) for 6 years; 
risk factors: negative H. pylori, constipation 
and calcium channel antagonists
    Mishima
      et al
77
Japan Referral populations:
2,760
2005 - GERD, QUEST question-
naire > 6; RE by LA classi-
fication
RE, 7.1% (195); GERD, 12.7% (351); 
NERD, 10.9% (300) 
    Okamoto
      et al
78
Japan Outpatients without tak-
ing GI medication (n =
6,166) and health check 
up (n = 1,865): N =
8,031
2003   1996-
1998
Direct interview; RE by LA 
classification
RE, 14.9% (1,199) without gender difference; 
heartburn, 27.7%; dysphagia, 19.0%; ody-
nophagia, 6.1%; acid regurgitation, 18.3%
    Chang
      et al
79
China Tertiary hospital: 2,044 1997 - RE by endoscopy  RE, 5%; gender difference (men : women =
5.6 : 1)
    Haruma
      et al
80
Japan Tertiary hospital: 6,205 2000   1995-
1997
RE, presence of hyperemia, 
erosion or ulcer
RE, 3.7% (229)
    Yeh
      et al
60
Taiwan 464 patients with GI sy-
mptoms
1997   1991-
1992
RE by Savary-Miller system RE, 14.5% (66); gender difference (men :
women = 3.1 : 1)
Asymptomatic reflux esophagitis was reported in 33.6%- 
84.0% among the subjects with reflux esophagitis.
32,34 This find-
ing might be a true reflection of community or caused by the pos-
sible over-diagnosis of endoscopic reflux esophagitis by including 
mild reflux esophagitis or minimal changes. 
Non-erosive reflux disease (NERD) has been commonly de-
fined as the presence of classic GERD symptoms in the absence 
of esophageal mucosal injury which has been detected during the 
upper endoscopy.
37 NERD is considered as the major subcate-
gory of GERD, which has been assumed with an increasingly im-
portant role. The prevalence of NERD in medical check-up stu-
dies was reported from 3.1% to 4.0%, comprising about 70%- Hye-Kyung Jung
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Table 3. Continued
Study Country
  Sample
size
Publi-
cation
year
Study
year
 Definition of study/Methods Prevalence
South Eastern Asia 
    Rosaida
      and 
      Goh
81
Malaysia 1,000 patients with upper 
abdominal discomfort
2004 - GERD, heartburn and/or acid 
regurgitation at least mon-
thly; RE by LA classifica-
tion.
GERD 38.8% (388); RE 13.4% (134); NERD
25.4% (254); Hiatal hernia 6.7% (67); risk 
factors for GERD: Indian race (OR, 3.25; 
95% CI, 2.38-4.45), Malay race (OR, 1.67; 
95% CI, 1.16-2.38), obesity, hiatus hernia, 
alcohol and high education; risk factors for 
RE: male, Indian race, hiatus hernia and 
alcohol consumption
    Ho
      et al
82 
Singapore 16,375 patients who were 
referred for endoscopy
2005   1992-
2001
RE, presence of erosions and/ 
or ulceration
RE 6.9% (1,128; 95% CI, 6.5-7.3); risk fac-
tors: year of endoscopy (OR, 1.99; 95% CI, 
1.18-3.36), positive urease test rate (OR, 
0.99; 95% CI, 0.983-0.999), male gender 
(OR, 1.59; 95% CI, 1.01-2.50)
South Central Asia 
    Yarandi
      et al
83 
Iran 6,476 patients with FGID 
symptoms
2010 - GERD, symptoms or endo-
scopic finding or pH moni-
toring; Rome II or III cri-
teria for FGIDs
GERD, 41% (2,658); IBS, 21.9% (1,419); 
significant overlap with IBS (63.6% in IBS 
vs 34.7% in non-IBS)
    Jafri
      et al
84
Pakistan 963 2005 - GERD GERD, 24% (228)
Western Asia
    Al-
      Humayed
      et al
85
Saudi
  Arabia
1,607 patients with dy-
spepsia who underwent 
endoscopy; retrospective 
review
2010 - GERD symptoms; endosco-
pic RE
GERD, 15% (242) with or without RE or 
hiatus hernia
GERD, gastroesophageal reflux disease; GI, gastrointestinal; FGID, functional gastrointestinal disorder; RE, Reflux esophagitis; LA, Los Angeles; NERD,
non-erosive reflux disease; QUEST, questionnaire for the diagnosis of reflux esophagitis; BMI, body mass index; H. pylori, Helicobacter pylori; IBS, irritable bowel 
syndrome.
80% of GERD.
34,35 Most studies using questionnaires might 
have over-estimated the prevalence of NERD because their ques-
tions might have failed to distinguish the functional heartburn.
38 
More precise data regarding the epidemiology of NERD are 
needed.
In referral hospital settings, the prevalence of GERD showed 
wide range results as followings: 12.4%-31.7% of symptom-ba-
sed GERD, 2.3%-14.7% of NERD and 7.1%-20.8% of endo-
scopic reflux esophagitis. In a time trend study in Chinese tertiary 
hospitals from 2000 to 2007, the prevalence of endoscopic reflux 
esophagitis increased from 20.7% to 51.0% with the increased 
numbers of undergoing endoscopy secondary to GERD from 
4.9% in 2000 to 14.1% in 2007. However, the prevalence of con-
comitant GERD symptoms did not significantly change (range, 
13.0%-15.1%) in screening endoscopic studies with no signifi-
cant interval change in the prevalence of NERD.
39 Therefore, 
those authors have suggested that the actual increase in the preva-
lence of endoscopic reflux esophagitis might be the result of the 
increased demand for endoscopic investigation of GERD symp-
toms in some populations, or the better recognition of reflux 
esophagitis by endoscopists. 
Prevalence of Extra-esophageal 
  Syndromes
Although typical manifestations of GERD are heartburn or 
acid regurgitation, atypical or extra-esophageal symptoms might 
also be presented including respiratory symptoms, such as chron-
ic cough, asthma or laryngitis, dental erosions, non-cardiac chest 
pain (NCCP), sleep disturbance and so on.
40 These syndromes Epidemiology of GERD in Asia
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Table 4. Extra-esophageal Syndrome of Gastroesophageal Reflux Disease in Asia
Symptoms Study Country
  Setting/Sample
  size
Publication
year
   Definition of study/
            Methods
Prevalence/Proportion
Asthma Takenaka
  et al
86
Japan Tertiary hospital 2010 Self-reported  questionnaires GERD, 27.4% in subjects with persistent 
moderate to severe asthma treated with
anti-inflammatory asthma medication
Asthma Bor et al
43 Turkey Tertiary hospital: 308
asthma, 133 COPD 
and 694 control
2009 GERD, heartburn/regur-
gitation at least weekly; 
case-control study
GERD, 25.4% in asthma, 17.0% in COPD 
and 19.4% in controls
Asthma Shimizu
  et al
44
Japan Tertiary hospital: 78 as-
thma, 56 non-asthmatic
disease control and 150
healthy control
2006 Case-control study; RE, LA 
classification
RE: 39.3% (22), 5.4% (3) and 0.6% (1) in 
asthma, non-asthmatic disease control and 
healthy control, respectively
Asthma Chunlertrith
  et al
87
Thailand Tertiary hospital: 151
asthma patients and 147
control 
2005 Case-control study; GERD, 
heartburn or acid regurgi-
tation
GERD, 12.6% in asthma vs 10.2% in control 
(P > 0.05)
Asthma Al-Asoom
  et al
88
Saudi
  Arabia
Tertiary hospital: 50 as-
thma patients and 22
control 
2003 Case-control study; GER, 
a DeMeester score > 14.7
Pathologic GER, 44% (22) in asthma; risk 
factors: hoarseness and nocturnal symptoms
Asthma Nakase
  et al
89
Japan 72 asthma patients in
tertiary hospital
1999 RE by LA classification RE, 27.8% (20); 67% (43) having one of the 
followings: heartburn, epigastric pain, wa-
ter brash, odynophagia and dysphagia
Sleep
  disturbance
Fujiwara
 et al
45
Japan Tertiary hospital: 134
GERD (82 NERD)
2010 Self-reported questionnaires 52.2% in 134 GERD; NERD for sleep dis-
turbance (OR, 2.18; 95% CI, 1.05-4.53)
Sleep
  disturbance
Chen et al
2 Taiwan Health check-up: 3,663 2009 Endoscopy: RE by LA cla-
ssification
Reflux symptoms for poor sleep quality (OR, 
2.05; 95% CI, 1.65-2.54)
Sleep
  disturbance
Kusano
  et al
46
Japan 35 nation-wide tertiary 
hospitals: N = 2,426
2008 Sleep disturbance defined 
by self reported question-
naire classification
Higher sleep disturbance in heartburn com-
pared to no heartburn (56.5% vs 40.7%, P
< 0.0001); no difference according to RE
Temporo-
  mandibular
  disorder
Gharaibeh
  et al
90
Jordan Tertiary hospital: 60
GERD vs 60 control
2009 Case-control study 36.6 % in GERD vs 18.3% in control (P =
0.025); myofascial pain, 31.7% vs 15% (P
=0 . 0 3 )
Dental
  erosion
Wang et al
47 China Tertiary hospital: N =
88
2010 Case-control study 64.5% in frequent reflux (3-5/wk), 44.4% in 
occasional (1-2/wk) and 36.7% in control 
(P < 0.05)
NCCP Mohd
 et al
49
Malaysia Tertiary hospital: 27
NCCP
2009
-
RE or 48 hr Bravo am-
bulatory pH monitoring
GERD, 66.7% (18/27) among NCCP
NCCP Bor et al
48 Turkey Population-based study:
630 in low-income re-
gion
2009 GERD, heartburn and/or 
acid eructation at least 
weekly
GERD, 20%; NCCP, 37.3%; dysphagia, 
35.7%; dyspepsia, 42.1%; odynophagia, 
35.7%
ENT
  symptoms
Toros et al
91 Turkey 45 ENT outpatients in 
Tertiary hospital
2008
-
Symptoms; RE by endo-
scopy
RE, 11%; GERD-related symptoms as sore 
throat, throat burning, throat clearing, 
globus, cough, halitosis, dysphonia, dyspha-
gia, postnasal dripping, vocal fatigue and 
sputum
Chronic
  laryngitis
Qua et al
92 Malaysia 32 chronic laryngitis pa-
tients in tertiary hos-
pital
2007 GERD, heartburn or acid 
regurgitation at least once 
a week
GERD, 65.6% (21) in chronic laryngitis
are usually considered to be multifactorial with GERD as one of 
the several potential aggravating cofactors.
1 Extra-esophageal syn-
dromes rarely occur with concomitant manifestations of the typi-
cal esophageal syndrome. Upper endoscopy and ambulatory pH 
monitoring were used to diagnose reflux in patients with atypical 
gastroesophageal reflux symptoms, however, these studies have Hye-Kyung Jung
22 Journal of Neurogastroenterology and Motility 
Table 4. Continued
Symptoms Study Country
  Setting/Sample
  size
Publication
year
    Definition of study/
             Methods
Prevalence/Proportion
Extra-
  esophageal
  symptoms
Cho et al
41 Korea Population-based study:
1,417
2005 Extra-esophageal symptoms, 
at least one of chest pain, 
dysphagia, globus sensa-
tion, asthma, bronchitis, 
pneumonia or hoarseness
GERD, 41.6% in atypical symptoms vs 8.7% 
in no atypical symptoms; chest pain, 44% in 
GERD vs 3.6% no-GERD; dysphagia,
16.0% vs 1.0%; globus 14.0% vs 1.1%; 
asthma, 26.0% vs 3.2%; bronchitis 20.0% 
vs 3.7%; hoarseness, 10.0% vs 0.6%; all P
<0 . 0 0 1
Extra-
  esophageal
   symptoms
Wang et al
42 China Population-based study:
2,532
2004
-
SGER, composite score of 
following 3 GER sympto-
ms ≥ 3
Snore in SGER vs no-SGER, 28.1% vs 
12.3%; laryngitis, 23.7% vs 11.8%; globus, 
23.7% vs 5.0%; asthma, 6.5% vs 2.2%; 
bronchitis, 15.4% vs 8.9%; chronic cough, 
21.4% vs 11.0%; all P <0 . 0 1
NCCP, non-cardiac chest pain; ENT, ear, nose and throat; COPD, chronic obstructive pulmonary disease; GERD, gastroesophageal reflux disease; NERD, 
non-erosive reflux disease; RE, reflux esophagitis; LA, Los Angeles; SGER, symptomatic gastroesophageal reflux. 
Figure. The prevalence of gastroesopha-
geal reflux disease in Asian population- 
based study. Gastroesophageal reflux di-
sease (GERD) is defined as having heart-
burn or acid regurgitation at least weekly. 
*Study conducted in subjects with medi-
cal check-up, **GERD, retrosternal bu-
rning sensation or acid regurgitation at
least once a month.
been proved to have poor diagnostic yield. 
Extra-esophageal syndromes of GERD in Asia are summar-
ized in Table 4. These data showed a wide range of prevalence or 
proportion because of the different definition of disease and dif-
ferent conditions of each study. 
Two population-based studies in Asia have demonstrated the 
association between extra-esophageal syndrome and GERD.
41,42 
The proportion of GERD was significantly higher in subjects 
with atypical symptoms than in controls (41.6% vs 8.7%, P <
0.05).
41 Symptoms as chest pain, dysphagia, globus, asthma, bron-
chitis, chronic cough and hoarseness were more frequently asso-
ciated with GERD than controls.
42
Both asthma and GERD are common conditions and they 
often coexist. However, several Western epidemiologic studies 
have revealed that asthma had been found more frequently in 
subjects with GERD than the general population.
1 The preva-
lence of GERD was higher in the asthma group compared with 
controls in one large scale study (n = 1,135), performed in Tur-
key (25.4% vs 19.4%, P < 0.05).
43 The proportion of endo-
scopic reflux esophagitis in patients with asthma was also higher 
than controls.
44 There have been several studies demonstrating 
the association between sleep disturbance and GERD. The pro-
portion of sleep dysfunction was 52.5%-56.6% among the pati-
ents with GERD, and GERD increased the OR of sleep dis-Epidemiology of GERD in Asia
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Table 5.  Epidemiology of Barrett’s Esophagus in Asia
Study Country
  Setting/Sample
  size
Publication
year
     Definition of study/
              Methods
Prevalence of Barrett’s esophagus
Xiong et al
55 China Referral hospital: 2,022 pa-
tients with upper abdo-
minal discomfort
2010 BE, ESCE with SIM BE, 1% (21); risk factors: age (OR, 1.03; 95% CI, 
1.00-1.07), RE (OR, 4.44; 95% CI, 1.22- 16.17)
Lee et al
56 Korea Referral hospital: 2,048 pa-
tients with upper abdo-
minal discomfort
2010 BE, a displacement of the 
squamocolumnar junction 
more than 1 cm with the 
presence of SIM
BE, 1% (21); risk factors: typical reflux symptoms 
(OR, 2.29; 95% CI, 1.16-7.37), RE (OR, 10.28; 
95% CI, 4.31-24.50)
Chen et al
39 China Tertiary hospital: 7,479 in 
2000 and 10,195 in 2007
2010 BE, SIM BE, 0.6% at 2000 and 1.2% at 2007
Peng et al
32 China Medical check-up: 2,580 2009 BE, SIM containing goblet 
cells 
BE, 1.0% (27); risk factors: reflux symptoms, 
hiatus hernia and alcohol use
Fouad et al
61 Egypt Tertiary hospital: 1,000 pa-
tients with GERD
2009 GERD, at least 3 times 
weekly; BE, columnar-lin-
ed esophagus at endoscopy 
with SIM
7.3% in chronic GERD; 0.08% (4/502) in NERD; 
adenocarcinoma, 0.8%
Park et al
57 Korea Medical health check-up: 
25,536
2009 BE, ESCE with SIM 0.84% (215); RE among BE, 33%; having sy-
mptoms among BE, 60.1%; risk factors: male 
sex (OR, 1.82; 95% CI, 1.32-2.50), NSAIDs 
(OR, 2.02; 95% CI, 1.28-3.20), hiatal hernia 
(OR, 5.66; 95% CI, 3.70-8.66) and age ≥ 60 yr 
compared with an age < 40 yr (OR, 1.81; 95% 
CI, 1.07-3.09)
Odemiş
  et al
58
Turkey Referral hospital: 1,000 con-
secutive patients
2009 BE,  ESCE  with  SIM 1.2% (12): 14% in hiatal hernia and 0.5% in 
normal esophago-gastric junction (P = 0.001)
Tseng et al
29 China Medical check-up: 19,812 2008 BE, ESCE with SIM  ESCE, 0.28% (56); BE, 0.06% (12); short seg-
ment BE, 91.7% of BE
Kim et al
54 Korea Tertiary hospital: retrospec-
tive review 70,103
2007 ESCE without SIM; BE, 
ESCE with SIM 
ESCE without SIM, 1% (696); BE, 0.22% (151); 
risk factors: old age, male gender, smoker and 
having symptoms of acid regurgitation
Bafandeh
  et al
62
Iran Tertiary hospital: 1,248 pa-
tients with heartburn
2005 Biopsy on columnar-lined 
mucosa above the GE ju-
nction, at 5 cm above the Z 
line
RE, 66.5% (960); BE, 2.4% (30); long-segment 
Barrett’s mucosa, 1/3 of BE
Gadour and
  Ayoola
59
Saudi
  Arabia
Tertiary hospital: 2,572 sub-
jects with endoscopy
1999 BE, endoscopic biopsy prov-
ed diagnosis
BE, 0.31% (8); esophageal adenocarcinoma, 
0.62% (16)
Rosaida and
  Goh
81
Malaysia Tertiary hospital: 1,000 pa-
tients with upper abdo-
minal discomfort
2004 BE, ESCE with SIM  BE, 2% (20)
Yeh et al
60 Taiwan Tertiary hospital: 464 pa-
tients with upper abdo-
minal discomfort
1997 BE, ESCE with intestinal 
metaplasia
BE, 2.0% (9)
GERD, gastroesophageal reflux disease; BE, Barrett’s esophagus; ESCE, endoscopic suspected columnar epithelium; SIM, specialized intestinal metaplasia; RE, reflux
esophagitis; NERD, non-erosive reflux disease.
turbance to about twice than controls.
2,45,46 
Dental erosion is an acid-induced loss of dental hard tissue 
without the involvement of bacteria. Direct contact of regurgi-
tated gastric acid is considered to be the main mechanism of den-
tal erosion in patients with GERD.
47 In tertiary hospitals, dental 
erosions were found in 64.5% among patients with frequent re-
flux symptoms (3-5 times/wk), 44.4% among subjects with occa-
sional symptoms (1-2 times/wk) and 36.7% among controls (PHye-Kyung Jung
24 Journal of Neurogastroenterology and Motility 
<0 . 0 5 ) .
47
NCCP is a heterogeneous and complex disorder with many 
potential causes including GERD. NCCP has been common in 
Asia
48 and GERD has also been frequently detected in NCCP, 
even though the proportions were different according to the diag-
nostic modalities.
48,49  
Prevalence of Barrett’s Esophagus
Barrett’s esophagus is histologically confirmed by specialized 
intestinal metaplasia.
50,51 It is considered to be one of the most 
important complications of GERD due to its strong association 
with adenocarcinoma. However, epidemiologic studies have con-
sistently reported that the prevalence of Barrett’s esophagus-as-
sociated adenocarcinoma is very rare in Asia.
52,53 The prevalence 
of Barrett’s esophagus was reported as 0.06%-0.84%
29,54 in medi-
cal check-up and 0.31%-2.00%
39,55-60 in the referral hospital sett-
ings (Table 5). The proportion of Barrett’s esophagus was 7.3%
61 
in patients with GERD and 2.4%
62 in those with heartburn sy-
mptoms. Importantly, esophageal adenocarcinoma is often found 
even without any medical history of reflux symptoms.
63 Although 
GERD symptoms is considered to be one of the most important 
risk factors of Barrett’s esophagus,
54-56 only 60.1% of subjects who 
had received the medical check-up were found to have GERD 
symptoms.
57 
In the Western world, esophageal adenocarcinoma has be-
come one of the increasing cancers, in parallel with the increased 
prevalence of GERD and its major determinant, obesity.
64,65 Such 
increase in the occurrence of Barrett’s esophagus has not yet been 
observed in Asia. Epidemiologic changes of GERD in Asia seem 
to be correlated with economic or environmental effects, Helico-
bacter pylori infections, nutritional changes, and also the geogra-
phic and ethnic differences.
53,66 The general low-fat diet of Asian, 
their smaller body mass and also their higher prevalence of He-
licobacter pylori might be related with the lower prevalence of 
GERD compared to Western peoples.
53 However, their rapid 
economic growth, changes of eating habits and also the growing 
number of obesity in people would induce many changes in the 
epidemiology of Barrett’s esophagus and esophageal adenocar-
cinoma in the future.
In conclusion, many robust studies about GERD in Asia 
have been published during recent decades. Population-based 
studies showed that the prevalence of GERD has been increased 
in Eastern Asia, but still lower than those of the Western popu-
lation. The prevalence of GERD in Southeast and Western Asia 
was higher than in Eastern Asia. The prevalence of endoscopic 
reflux esophagitis in Eastern Asia seemed to increase in partic-
ipants who have received the medical check-up. In Asia, only few 
and limited studies have been reported regarding the proportion 
of extra-esophageal syndromes such as asthma, sleep disturbance, 
non-cardiac chest pain and dental erosion, which was found to be 
significantly higher in the GERD patient group than controls. 
On the other hand, the prevalence of Barrett’s esophagus was 
found to be relatively low.
Based on the distinct genetic characteristics compared from 
the Western people, and rapid changes of socio-economic envi-
ronments, this kind of study observing and investigating the epi-
demiologic changes of GERD in Asia would be a good model to 
understand the underlying pathogenesis of GERD. 
References
1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Con-
sensus Group. The Montreal definition and classification of gastro-
esophageal reflux disease: a global evidence-based consensus. Am J 
Gastroenterol 2006;101:1900-1920. 
2. Chen MJ, Wu MS, Lin JT, et al. Gastroesophageal reflux disease 
and sleep quality in a Chinese population. J Formos Med Assoc 
2009;108:53-60.
3. Kang JY. Systematic review: geographical and ethnic differences in 
gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2004; 
20:705-717.
4. El-Serag HB. Time trends of gastroesophageal reflux disease: a sys-
tematic review. Clin Gastroenterol Hepatol 2007;5:17-26.
5. Fock KM, Talley NJ, Fass R, et al. Asia-Pacific consensus on the 
management of gastroesophageal reflux disease: update. J Gastroen-
terol Hepatol 2008;23:8-22.
6. Goh KL, Chang CS, Fock KM, Ke M, Park HJ, Lam SK. Gastro- 
oesophageal reflux disease in Asia. J Gastroenterol Hepatol 2000; 
15:230-238.
7. GLOBOCAN 2008: Cancer incidence and mortality worldwide in 
2008. International agency for research on cancer; 2008. Available 
from http://globocan.iarc.fr. 
8. He J, Ma X, Zhao Y, et al. A population-based survey of the epi-
demiology of symptom-defined gastroesophageal reflux disease: the 
Systematic Investigation of Gastrointestinal Diseases in China. BMC 
Gastroenterol 2010;10:94. 
9. Wang R, Yan X, Ma XQ, et al. Burden of gastroesophageal reflux 
disease in Shanghai, China. Dig Liver Dis 2009;41:110-115.
10. Lee SY, Lee KJ, Kim SJ, Cho SW. Prevalence and risk factors for 
overlaps between gastroesophageal reflux disease, dyspepsia, and irri-
table bowel syndrome: a population-based study. Digestion 2009;79: 
196-201.
11. Yang SY, Lee OY, Bak YT, et al. Prevalence of gastroesophageal re-
flux disease symptoms and uninvestigated dyspepsia in Korea: a 
population-based study. Dig Dis Sci 2008;53:188-193.
12. Li YM, Du J, Zhang H, Yu CH. Epidemiological investigation in Epidemiology of GERD in Asia
25 Vol. 17, No. 1 January, 2011 (14-27)
outpatients with symptomatic gastroesophageal reflux from the De-
partment of Medicine in Zhejiang Province, east China. J Gastroen-
terol Hepatol 2008;23:283-289. 
13. Chen M, Xiong L, Chen H, Xu A, He L, Hu P. Prevalence, risk 
factors and impact of gastroesophageal reflux disease symptoms: a 
population-based study in South China. Scand J Gastroenterol 2005; 
40:759-767.
14. Wong WM, Lai KC, Lam KF, et al. Prevalence, clinical spectrum 
and health care utilization of gastro-oesophageal reflux disease in a 
Chinese population: a population-based study. Aliment Pharmacol 
Ther 2003;18:595-604.
15. Jeong JJ, Choi MG, Cho YS, et al. Chronic gastrointestinal symp-
toms and quality of life in the Korean population. World J Gastro-
enterol 2008;14:6388-6394.
16. Cheung TK, Lam KF, Hu WH, et al. Positive association between 
gastro-oesophageal reflux disease and irritable bowel syndrome in a 
Chinese population. Aliment Pharmacol Ther 2007;25:1099-1104.
17. Solhpour A, Pourhoseingholi MA, Soltani F, et al. Gastro-esoph-
ageal reflux symptoms and body mass index: no relation among the 
Iranian population. Indian J Gastroenterol 2008;27:153-155.
18. Nasseri-Moghaddam S, Mofid A, Ghotbi MH, et al. Epidemio-
logical study of gastro-oesophageal reflux disease: reflux in spouse as 
a risk factor. Aliment Pharmacol Ther 2008;28:144-153.
19. Somi MH, Farhang S, Mirinezhad K, et al. Prevalence and precip-
itating factors of gastroesophageal reflux disease in a young pop-
ulation of Tabriz, Northwest of Iran. Saudi Med J 2006;27:1878- 
1881.
20. Nouraie M, Razjouyan H, Assady M, Malekzadeh R, Nasseri-Mo-
ghaddam S. Epidemiology of gastroesophageal reflux symptoms in 
Tehran, Iran: a population-based telephone survey. Arch Iran Med 
2007;10:289-294.
21. Saberi-Firoozi M, Khademolhosseini F, Yousefi M, Mehrabani D, 
Zare N, Heydari ST. Risk factors of gastroesophageal reflux disease 
in Shiraz, southern Iran. World J Gastroenterol 2007;13:5486-5491.
22. Ehsani MJ, Maleki I, Mohammadzadeh F, Mashayekh A. Epide-
miology of gastroesophageal reflux disease in Tehran, Iran. J Gas-
troenterol Hepatol 2007;22:1419-1422.
23. Lim SL, Goh WT, Lee JM, Ng TP, Ho KY; Community Medicine 
GI Study Group. Changing prevalence of gastroesophageal reflux 
with changing time: longitudinal study in an Asian population. J 
Gastroenterol Hepatol 2005;20:995-1001.
24. Sperber AD, Halpern Z, Shvartzman P, et al. Prevalence of GERD 
symptoms in a representative Israeli adult population. J Clin Gas-
troenterol 2007;41:457-461.
25. Lee SJ, Song CW, Jeen YT, et al. Prevalence of endoscopic reflux 
esophagitis among Koreans. J Gastroenterol Hepatol 2001;16:373- 
376.
26. Lien HC, Chang CS, Yeh HZ, et al. Increasing prevalence of erosive 
esophagitis among Taiwanese aged 40 years and above: a comparison 
between two time periods. J Clin Gastroenterol 2009;43:926-932.
27. Fujimoto K, Iwakiri R, Okamoto K, et al. Characteristics of gastro-
esophageal reflux disease in Japan: increased prevalence in elderly wo-
men. J Gastroenterol 2003;38(suppl 15):3-6.
28. Fujiwara Y, Higuchi K, Shiba M, et al. Association between gastro-
esophageal flap valve, reflux esophagitis, Barrett's epithelium, and 
atrophic gastritis assessed by endoscopy in Japanese patients. J Gas-
troenterol 2003;38:533-539.
29. Tseng PH, Lee YC, Chiu HM, et al. Prevalence and clinical charac-
teristics of Barrett's esophagus in a Chinese general population. J Clin 
Gastroenterol 2008;42:1074-1079.
30. Lee HL, Eun CS, Lee OY, et al. Association between GERD-re-
lated erosive esophagitis and obesity. J Clin Gastroenterol 2008;42: 
672-675.
31. Kang MS, Park DI, Oh SY, et al. Abdominal obesity is an in-
dependent risk factor for erosive esophagitis in a Korean population. 
J Gastroenterol Hepatol 2007;22:1656-1661.
32. Peng S, Cui Y, Xiao YL, et al. Prevalence of erosive esophagitis and 
Barrett's esophagus in the adult Chinese population. Endoscopy 
2009;41:1011-1017.
33. Yamagishi H, Koike T, Ohara S, et al. Clinical characteristics of gas-
troesophageal reflux disease in Japan. Hepatogastroenterology 2009; 
56:1032-1034.
34. Kim N, Lee SW, Cho SI, et al. The prevalence of and risk factors for 
erosive oesophagitis and non-erosive reflux disease: a nationwide mul-
ticentre prospective study in Korea. Aliment Pharmacol Ther 2008; 
27:173-185.
35. Noh YW, Jung HK, Kim SE, Jung SA. Overlap of erosive and 
non-erosive reflux diseases with functional gastrointestinal disorders 
according to Rome III criteria. J Neurogastroenterol Motil 2010;16: 
148-156.
36. Kaji M, Fujiwara Y, Shiba M, et al. Prevalence of overlaps bet-
ween GERD, FD and IBS and impact on health-related quality of 
life. J Gastroenterol Hepatol 2010;25:1151-1156.
37. Hershcovici T, Fass R. Nonerosive reflux disease (NERD) - an 
update. J Neurogastroenterol Motil 2010;16:8-21.
38. Modlin IM, Hunt RH, Malfertheiner P, et al. Non-erosive reflux 
disease - defining the entity and delineating the management. Di-
gestion 2008;78(suppl 1):1-5.
39. Chen MJ, Lee YC, Chiu HM, Wu MS, Wang HP, Lin JT. Time 
trends of endoscopic and pathological diagnoses related to gastro-
esophageal reflux disease in a Chinese population: eight years single 
institution experience. Dis Esophagus 2010;23:201-207.
40. Koop H, Schepp W, Müller-Lissner S, et al. Consensus conference 
of the DGVS on gastroesophageal reflux. Z Gastroenterol 2005;43: 
163-164.
41. Cho YS, Choi MG, Jeong JJ, et al. Prevalence and clinical spectrum 
of gastroesophageal reflux: a population-based study in Asan-si, Ko-
rea. Am J Gastroenterol 2005;100:747-753.
42. Wang JH, Luo JY, Dong L, Gong J, Tong M. Epidemiology of 
gastroesophageal reflux disease: a general population-based study in 
Xi'an of Northwest China. World J Gastroenterol 2004;10:1647- 
1651.
43. Bor S, Kitapcioglu G, Solak ZA, Ertilav M, Erdinc M. Prevalence of 
gastroesophageal reflux disease in patients with asthma and chronic 
obstructive pulmonary disease. J Gastroenterol Hepatol 2010;25: 
309-313.
44. Shimizu Y, Dobashi K, Kobayashi S, et al. High prevalence of gastro-
esophageal reflux disease with minimal mucosal change in asthmatic 
patients. Tohoku J Exp Med 2006;209:329-336.
45. Fujiwara Y, Kohata Y, Kaji M, et al. Sleep dysfunction in Japanese 
patients with gastroesophageal reflux disease: prevalence, risk factors, 
and efficacy of rabeprazole. Digestion 2010;81:135-141.Hye-Kyung Jung
26 Journal of Neurogastroenterology and Motility 
46. Kusano M, Kouzu T, Kawano T, Ohara S. Nationwide epidemio-
logical study on gastroesophageal reflux disease and sleep disorders in 
the Japanese population. J Gastroenterol 2008;43:833-841.
47. Wang GR, Zhang H, Wang ZG, Jiang GS, Guo CH. Relationship 
between dental erosion and respiratory symptoms in patients with 
gastro-oesophageal reflux disease. J Dent 2010;38:892-898.
48. Bor S, Mandiracioglu A, Kitapcioglu G, Caymaz-Bor C, Gilbert RJ. 
Gastroesophageal reflux disease in a low-income region in Turkey. 
Am J Gastroenterol 2005;100:759-765.
49. Mohd H, Qua CS, Wong CH, Azman W, Goh KL. Non-cardiac 
chest pain: prevalence of reflux disease and response to acid sup-
pression in an Asian population. J Gastroenterol Hepatol 2009;24: 
288-293.
50. Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, 
Wong RK. Specialized intestinal metaplasia, dysplasia, and cancer of 
the esophagus and esophagogastric junction: prevalence and clinical 
data. Gastroenterology 1999;116:277-285.
51. Spechler SJ. The columnar-lined esophagus. History, terminology, 
and clinical issues. Gastroenterol Clin North Am 1997;26:455-466.
52. Tu CH, Lee CT, Perng DS, Chang CC, Hsu CH, Lee YC. Eso-
phageal adenocarcinoma arising from Barrett's epithelium in Taiwan. 
J Formos Med Assoc 2007;106:664-668.
53. Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: 
Orient to Occident. Effects of chronology, geography and ethnicity. 
J Gastroenterol Hepatol 2009;24:729-735.
54. Kim JH, Rhee PL, Lee JH, et al. Prevalence and risk factors of 
Barrett's esophagus in Korea. J Gastroenterol Hepatol 2007;22:908- 
912.
55. Xiong LS, Cui Y, Wang JP, et al. Prevalence and risk factors of 
Barrett's esophagus in patients undergoing endoscopy for upper gas-
trointestinal symptoms. J Dig Dis 2010;11:83-87.
56. Lee IS, Choi SC, Shim KN, et al. Prevalence of Barrett's esophagus 
remains low in the Korean population: nationwide cross-sectional pro-
spective multicenter study. Dig Dis Sci 2010;55:1932-1939.
57. Park JJ, Kim JW, Kim HJ, et al. The prevalence of and risk factors 
for Barrett's esophagus in a Korean population: a nationwide multi-
center prospective study. J Clin Gastroenterol 2009;43:907-914.
58. Odemiş B, Ciçek B, Zengin NI, et al. Barrett's esophagus and endo-
scopically assessed esophagogastric junction integrity in 1000 consec-
utive Turkish patients undergoing endoscopy: a prospective study. 
Dis Esophagus 2009;22:649-655.
59. Gadour MO, Ayoola EA. Barrett's oesophagus and oesophageal 
cancer in Saudi Arabia. Trop Gastroenterol 1999;20:111-115.
60. Yeh C, Hsu CT, Ho AS, Sampliner RE, Fass R. Erosive esoph-
agitis and Barrett's esophagus in Taiwan: a higher frequency than 
expected. Dig Dis Sci 1997;42:702-706.
61. Fouad YM, Makhlouf MM, Tawfik HM, el-Amin H, Ghany WA, 
el-Khayat HR. Barrett's esophagus: prevalence and risk factors in pa-
tients with chronic GERD in Upper Egypt. World J Gastroenterol 
2009;15:3511-3515.
62. Bafandeh Y, Esmaili H, Aharizad S. Endoscopic and histologic find-
ings in Iranian patients with heartburn. Indian J Gastroenterol 2005; 
24:236-238.
63. Bytzer P, Christensen PB, Damkier P, Vinding K, Seersholm N. 
Adenocarcinoma of the esophagus and Barrett's esophagus: a pop-
ulation-based study. Am J Gastroenterol 1999;94:86-91.
64. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence 
of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 
265:1287-1289.
65. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the in-
cidence of esophageal and gastric carcinoma in the United States. 
Cancer 1998;83:2049-2053.
66. Blaser MJ. Hypothesis: the changing relationships of Helicobacter 
pylori and humans: implications for health and disease. J Infect Dis 
1999;179:1523-1530.
67. Ma XQ, Cao Y, Wang R, et al. Prevalence of, and factors associated 
with, gastroesophageal reflux disease: a population-based study in 
Shanghai, China. Dis Esophagus 2009;22:317-322.
68. Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms 
in a multiracial Asian population, with particular reference to reflux- 
type symptoms. Am J Gastroenterol 1998;93:1816-1822.
69. Mostaghni A, Mehrabani D, Khademolhosseini F, et al. Prevalence 
and risk factors of gastroesophageal reflux disease in Qashqai migrat-
ing nomads, southern Iran. World J Gastroenterol 2009;15:961-965.
70. Kitapçioğlu G, Mandiracioğlu A, Caymaz Bor C, Bor S. Overlap of 
symptoms of dyspepsia and gastroesophageal reflux in the commu-
nity. Turk J Gastroenterol 2007;18:14-19.
71. Matsuzaki J, Suzuki H, Iwasaki E, Yokoyama H, Sugino Y, Hibi T. 
Serum lipid levels are positively associated with non-erosive reflux 
disease, but not with functional heartburn. Neurogastroenterol Motil 
2010;22:965-970, e251.
72. Yamagishi H, Koike T, Ohara S, et al. Prevalence of gastroesopha-
geal reflux symptoms in a large unselected general population in Ja-
pan. World J Gastroenterol 2008;14:1358-1364.
73. Fujiwara Y, Higuchi K, Watanabe Y, et al. Prevalence of gastroeso-
phageal reflux disease and gastroesophageal reflux disease symptoms 
in Japan. J Gastroenterol Hepatol 2005;20:26-29.
74. Sakaguchi M, Oka H, Hashimoto T, et al. Obesity as a risk factor 
for GERD in Japan. J Gastroenterol 2008;43:57-62.
75. Du J, Liu J, Zhang H, Yu CH, Li YM. Risk factors for gastro-
esophageal reflux disease, reflux esophagitis and non-erosive reflux 
disease among Chinese patients undergoing upper gastrointestinal 
endoscopic examination. World J Gastroenterol 2007;13:6009-6015.
76. Miyamoto M, Haruma K, Kuwabara M, Nagano M, Okamoto T, 
Tanaka M. High incidence of newly-developed gastroesophageal re-
flux disease in the Japanese community: a 6-year follow-up study. J 
Gastroenterol Hepatol 2008;23:393-397.
77. Mishima I, Adachi K, Arima N, et al. Prevalence of endoscopically 
negative and positive gastroesophageal reflux disease in the Japanese. 
Scand J Gastroenterol 2005;40:1005-1009.
78. Okamoto K, Iwakiri R, Mori M, et al. Clinical symptoms in endo-
scopic reflux esophagitis: evaluation in 8031 adult subjects. Dig Dis 
Sci 2003;48:2237-2241.
79. Chang CS, Poon SK, Lien HC, Chen GH. The incidence of reflux 
esophagitis among the Chinese. Am J Gastroenterol 1997;92:668- 
671.
80. Haruma K, Hamada H, Mihara M, et al. Negative association be-
tween Helicobacter pylori infection and reflux esophagitis in older pa-
tients: case-control study in Japan. Helicobacter 2000;5:24-29.
81. Rosaida MS, Goh KL. Gastro-oesophageal reflux disease, reflux oe-
sophagitis and non-erosive reflux disease in a multiracial Asian pop-
ulation: a prospective, endoscopy based study. Eur J Gastroenterol Epidemiology of GERD in Asia
27 Vol. 17, No. 1 January, 2011 (14-27)
Hepatol 2004;16:495-501.
82. Ho KY, Chan YH, Kang JY. Increasing trend of reflux esophagitis 
and decreasing trend of Helicobacter pylori infection in patients from 
a multiethnic Asian country. Am J Gastroenterol 2005;100:1923- 
1928.
83. Yarandi SS, Nasseri-Moghaddam S, Mostajabi P, Malekzadeh R. 
Overlapping gastroesophageal reflux disease and irritable bowel syn-
drome: increased dysfunctional symptoms. World J Gastroenterol 
2010;16:1232-1238.
84. Jafri N, Yakoob J, Islam M, Manzoor S, Jalil A, Hashmi F. Percep-
tion of gastroesophageal reflux disease in urban population in Pakis-
tan. J Coll Physicians Surg Pak 2005;15:532-534.
85. Al-Humayed SM, Mohamed-Elbagir AK, Al-Wabel AA, Argobi 
YA. The changing pattern of upper gastro-intestinal lesions in south-
ern Saudi Arabia: an endoscopic study. Saudi J Gastroenterol 2010; 
16:35-37.
86. Takenaka R, Matsuno O, Kitajima K, et al. The use of frequency 
scale for the symptoms of GERD in assessment of gastro-oesophag-
eal reflex symptoms in asthma. Allergol Immunopathol (Madr) 
2010;38:20-24.
87. Chunlertrith K, Boonsawat W, Zaeoue U. Prevalence of gastroeso-
phageal reflux symptoms in asthma patients at Srinagarind Hospital. 
J Med Assoc Thai 2005;88:668-671.
88. Al-Asoom L, Al-Rubaish AM, El-Munshid HA, Al-Nafaie AN, 
Bukharie HA, Abdulrahman IS. Gastroesophageal reflux in bron-
chial asthma patients. A clinical note. Saudi Med J 2003;24:1364- 
1369.
89. Nakase H, Itani T, Mimura J, et al. Relationship between asthma 
and gastro-oesophageal reflux: significance of endoscopic grade of 
reflux oesophagitis in adult asthmatics. J Gastroenterol Hepatol 1999; 
14:715-722.
90. Gharaibeh TM, Jadallah K, Jadayel FA. Prevalence of temporoman-
dibular disorders in patients with gastroesophageal reflux disease: a 
case-controlled study. J Oral Maxillofac Surg 2010;68:1560-1564.
91. Toros SZ, Toros AB, Yüksel OD, Ozel L, Akkaynak C, Naiboglu 
B. Association of laryngopharyngeal manifestations and gastroeso-
phageal reflux. Eur Arch Otorhinolaryngol 2009;266:403-409.
92. Qua CS, Wong CH, Gopala K, Goh KL. Gastro-oesophageal reflux 
disease in chronic laryngitis: prevalence and response to acid-sup-
pressive therapy. Aliment Pharmacol Ther 2007;25:287-295.